Biotech Values

[DewDiligence]

Beware of biotech companies who issue folksy letters to shareholders from the CEO; CVM is a case in point:

http://finance.yahoo.com/news/CEL-SCI-Corporation-Releases-bw-4123257218.html?x=0

During 2011, we made great operational progress in bringing our investigational cancer drug Multikine® (Leukocyte Interleukin, Injection) closer to market. Our Phase III clinical trial for head and neck cancer, which is designed to prove to the most rigorous standards that Multikine works, was launched in dozens of hospitals located in eight countries on three continents. This trial is the largest head and neck cancer trial in the world. All of us at CEL-SCI are very proud of this major accomplishment.

What a crock.